Indian generic medicine scores big win, as cheaper oral SMA drug promises relief

The Swiss company Roche, maker of the oral SMA drug Risdiplam (marketed as Evrysdi), priced at more than INR Rs 6 lakh per bottle, had gone to the Supreme Court with a petition to challenge a Delhi High Court order in favour of the Indian company Natco, which has a generic version that costs about INR 16,000 per bottle.

About Hashtag: #BusinessNews

Get latest and breaking business updates and success stories of Indians residing across the world. We cover World Economics, Finance, Stock Markets, IPO, Banking and Industrial topics, Indian origin entrepreneurs